6QNS: Botulinum neurotoxin type B

Crystal structure of the binding domain of Botulinum Neurotoxin type B mutant I1248W/V1249W in complex with human synaptotagmin 1 and GD1a receptors. Determined by X-ray diffraction at 2.4 Å resolution. Released 26 Feb 2020.

Method
X-ray diffraction
Resolution
2.4 Å
Organisms
Clostridium botulinum, Homo sapiens
Chains
2
Atoms
3,986
Mol. weight
56.95 kDa
Released
26 Feb 2020

Explore 6QNS in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

6QNS contains 9 α-helices and 44 β-strands across 2 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 8 helices, 44 β-strands

ElementResiduesLengthSheet
β-strand864-86741
β-strand868-87032
β-strand875-87732
β-strand884-88743
β-strand892-89321
β-strand898-90141
β-strand909-91243
β-strand92214
β-strand927-93371
α-helix939-9413
α-helix942-9476
β-strand949-95793
β-strand960-96783
β-strand970-97673
β-strand982-98873
β-strand1003-100971
β-strand1013-101861
β-strand1021-102771
β-strand103514
β-strand1040-104563
β-strand1054-106291
α-helix1068-107912
β-strand108315
β-strand108516
β-strand109116
α-helix10921
β-strand109317
β-strand109818
β-strand1099-110249
β-strand1108-111258
α-helix11131
β-strand1119-112358
α-helix1124-11252
β-strand1126110
β-strand1137110
β-strand1145-114958
β-strand116017
β-strand116215
β-strand1166-117388
β-strand1176-118168
β-strand1182-1183211
β-strand1190-119238
α-helix11931
β-strand1194-119748
β-strand1204-1205211
β-strand1207-121158
β-strand122119
β-strand1222-122658
β-strand1234-1246138
β-strand1252-126098
α-helix1263-12664
β-strand1280-128349
Chain S: 1 helix, 0 β-strands
ElementResiduesLengthSheet
α-helix39-5113

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Botulinum neurotoxin type BAprotein442Clostridium botulinumP10844 (AlphaFold model)
Synaptotagmin-1Sprotein21Homo sapiensP21579 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>6QNS_1 Botulinum neurotoxin type B (chains A)
GSHMASMNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFKLTSSANSKI
RVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNSGWKISIRGN
RIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYINGKLESNTDIK
DIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSYSEYLKDFWG
NPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLYIGEKFIIRR
KSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEEEKLFLAPISDSDEFYNTIQ
IKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGWWFEEYKDYFCISKWYLKEVKR
KPYNLKLGCNWQFIPKDEGWTE
Sequence of entity 2 (S), FASTA
>6QNS_2 Synaptotagmin-1 (chains S)
GEGKEDAFSKLKEKFMNELHK

Primary citation

Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy. Yin, L., Masuyer, G., Zhang, S. et al. PLoS Biol (2020) 18:e3000618-e3000618. DOI 10.1371/journal.pbio.3000618 · PubMed

Other PDB entries of the same protein (UniProt P10844 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 6QNS directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.